The Latest Breaking News from FDA

Clinicians are ‘skittish’ about the Covid antiviral, resulting in a failure to treat patients who could greatly benefit

Bristol Myers Squibb (NYSE:BMY) received European Medicines Agency (EMA) Positive CHMP Opinion recommending approval for Opdualag (nivolumab and relatlimab) for treatment of patients with Unresectable or Metastatic Melanoma based on results from the Phase 2/3 RELATIVITY-047 trial. Bristol Myers shares traded in a range of $72.48 to $73.61 on a…

Plus: Electoral count reform, freeing baby formula from useless regulation, and more...

Elaborate labeling requirements blocked the importation of direly needed European baby formula.

In the wake of Dobbs, the Democratic-controlled House is passing a flurry of bills to "codify" constitutional rights that are not really in jeopardy. Yesterday, I wrote about the Respect For Marriage Act, which would require a state to recognize same-sex marriages performed in another state. This bill passed with…

WASHINGTON — The House on Thursday passed legislation that would codify the federal right to contraception, although the measure faces slim odds in the Senate because of GOP concerns about the broadness of the bill.

The Senate majority leader's 296-page bill would compound the barriers to successful legalization.

Paxlovid has been highly effective at reducing the risks of hospitalization and death, but some patients report a "Paxlovid rebound," in which the disease returns.

Low blood oxygen levels and lung issues led officials to believe Trump might have to be put on ventilator in 2020